Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds
Abstract
Metallopeptides with a sequence of a biologically active gamma-melanocyte stimulating hormone sequence of length n residues, wherein a residue including a nitrogen atom and sulfur atom each available for complexation to a metal ion is inserted at any position from between the two and three position to the C-terminus side of the n position, or alternatively is substituted for the residue at any position from the three position to the n position, with a metal ion complexed thereto, with any proline (Pro) residue which is either of the two residues on the immediately adjacent N-terminus side of the inserted or substituent residue comprising a nitrogen atom and sulfur atom available for complexation to a metal ion is substituted with a homolog.
Claims
exact text as granted — not AI-modified1 . A metallopeptide comprising a biologically active gamma-melanocyte stimulating hormone (γ-MSH) sequence of length n residues, wherein a residue comprising a nitrogen atom and sulfur atom each available for complexation to a metal ion is inserted at any position from between the two and three position to the C-terminus side of the n position, with a metal ion complexed thereto, wherein any proline (Pro) residue which is either of the two residues on the immediately adjacent N-terminus side of the inserted residue comprising a nitrogen atom and sulfur atom available for complexation to a metal ion is substituted with a homolog.
2 . The metallopeptide of claim 1 wherein the metal ion is rhenium.
3 . The metallopeptide of claim 1 wherein the γ-MSH sequence is Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Phe-NH 2 .
4 . The metallopeptide of claim 3 wherein the residue comprising a nitrogen and sulfur atom is L-Cys and the metallopeptide sequence is selected from the group consisting of:
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Phe-Cys-
NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Cys-Phe-
NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Cys-Arg-Phe-
NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Cys-Asp-Arg-Phe-
NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Cys-Trp-Asp-Arg-Phe-
NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Cys-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
Tyr-Val-Nle-Gly-His-Cys-D-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
Tyr-Val-Nle-Gly-His-Cys-D-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
Tyr-Val-Nle-Gly-Cys-His-D-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
Tyr-Val-Nle-Cys-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
or
Tyr-Val-Cys-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 .
5 . The metallopeptide of claim 1 , wherein the γ-MSH sequence is Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH 2 (SEQ ID NO:14).
6 . The metallopeptide of claim 5 wherein the residue comprising a nitrogen and sulfur atom is L-Cys and the metallopeptide sequence is selected from the group consisting of:
(SEQ ID NO: 15)
Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Cys-
NH 2 ,
(SEQ ID NO: 16)
Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Cys-Phe-
NH 2 ,
(SEQ ID NO: 17)
Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Cys-Arg-Phe-
NH 2 ,
(SEQ ID NO: 18)
Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Cys-Asp-Arg-Phe-
NH 2 ,
(SEQ ID NO: 19)
Tyr-Val-Nle-Gly-His-Phe-Arg-Cys-Trp-Asp-Arg-Phe-
NH 2 ,
(SEQ ID NO: 20)
Tyr-Val-Nle-Gly-His-Phe-Cys-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
(SEQ ID NO: 21)
Tyr-Val-Nle-Gly-His-Cys-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
(SEQ ID NO: 22)
Tyr-Val-Nle-Gly-Cys-His-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
(SEQ ID NO: 23)
Tyr-Val-Nle-Cys-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 ,
or
(SEQ ID NO: 24)
Tyr-Val-Cys-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-
NH 2 .
7 . A metallopeptide comprising a biologically active γ-MSH sequence of length n residues, wherein a residue comprising a nitrogen atom and sulfur atom each available for complexation to a metal ion is substituted for the residue at any position from the three position to the n position, with a metal ion complexed thereto, wherein any Pro residue which is either of the two residues on the immediately adjacent N-terminus side of the substituent residue comprising a nitrogen atom and sulfur atom available for complexation to a metal ion is substituted with a homolog.
8 . The metallopeptide of claim 7 wherein the metal ion is rhenium.
9 . The metallopeptide of claim 8 wherein the γ-MSH sequence is Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Phe-NH 2 .
10 . The metallopeptide of claim 9 wherein the residue comprising a nitrogen and sulfur atom is L-Cys and the metallopeptide sequence is selected from the group consisting of:
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Cys-NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Asp-Cys-Phe-NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Trp-Cys-Arg-Phe-NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Arg-Cys-Asp-Arg-Phe-NH 2 ,
Tyr-Val-Nle-Gly-His-D-Phe-Cys-Trp-Asp-Arg-Phe-NH 2 ,
(SEQ ID NO: 66)
Tyr-Val-Nle-Gly-His-Cys-Arg-Trp-Asp-Arg-Phe-NH 2 ,
Tyr-Val-Nle-Gly-Cys-D-Phe-Arg-Trp-Asp-Arg-Phe-NH 2 ,
Tyr-Val-Nle-Cys-His-D-Phe-Arg-Trp-Asp-Arg-Phe-NH 2 ,
or
Tyr-Val-Cys-Gly-His-D-Phe-Arg-Trp-Asp-Arg-Phe-NH 2 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.